Karvellas, C J
81  Ergebnisse:
Personensuche X
?
1

A227 THE EFFECTIVENESS OF PEG 3350 COMPARED TO LACTULOSE FO..:

Afzaal, T ; Karvellas, C J ; Dionne, J
Journal of the Canadian Association of Gastroenterology.  5 (2022)  Supplement_1 - p. 118-119 , 2022
 
?
3

A56 THE USE OF HIGH VOLUME PLASMAPHARESIS IN ACUTE LIVER FA..:

Karvellas, C J ; Sy, E ; Tam, L
Journal of the Canadian Association of Gastroenterology.  3 (2020)  Supplement_1 - p. 65-67 , 2020
 
?
4

A22 LIVER TYPE FATTY ACID BINDING PROTEIN (FABP1) LEVELS IM..:

Karvellas, C J ; Speiser, J L ; Tremblay, M..
Journal of the Canadian Association of Gastroenterology.  1 (2018)  suppl_1 - p. 40-41 , 2018
 
?
5

A322 ALBUMIN MODIFIED BODY MASS INDEX FOR THE ASSESSMENT OF..:

Rueda-Clausen, C F ; Cardoso, F S ; Kneteman, N..
Journal of the Canadian Association of Gastroenterology.  1 (2018)  suppl_1 - p. 559-560 , 2018
 
?
 
?
7

A73 SURVIVAL PREDICTORS IN PATIENTS UNDERGOING LIVER TRANSP..:

Rueda-Clausen, C F ; Cardoso, F S ; Kneteman, N..
Journal of the Canadian Association of Gastroenterology.  1 (2018)  suppl_1 - p. 124-125 , 2018
 
?
10

Assessment of Prognostic Scores in Acute on Chronic Liver F..:

Sy, E. ; Ronco, J. ; Karvellas, C.
Journal of Hepatology.  64 (2016)  2 - p. S255-S256 , 2016
 
?
11

The impact of delayed biliary decompression and anti‐microb..:

Karvellas, C. J. ; Abraldes, J. G. ; Zepeda‐Gomez, S....
Alimentary Pharmacology & Therapeutics.  44 (2016)  7 - p. 755-766 , 2016
 
?
 
?
13

Letter: what else can improve survival in cirrhotic patient..:

Karvellas, C. J. ; Abraldes, J. G. ; Arabi, Y...
Alimentary Pharmacology & Therapeutics.  42 (2015)  1 - p. 123-124 , 2015
 
?
15

Appropriate and timely antimicrobial therapy in cirrhotic p..:

Karvellas, C. J. ; Abraldes, J. G. ; Arabi, Y. M...
Alimentary Pharmacology & Therapeutics.  41 (2015)  8 - p. 747-757 , 2015
 
1-15